Document
type: Class

individual
rights: termsOfUse
date: 2026-08-24T07:39:56
publisher: Anti-cancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.
type: Document
label: RDF description of Anti-cancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab. - http://irises.uniss.it/resource/item/3997

Academic Article
type: Class

Continuant
type: Class

Entity
type: Class

Anti-cancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.
type: Thing
type: Document
related by: 2862339
type: Information Content Entity
type: Continuant
type: Article
type: Academic Article
type: Entity
type: Generically Dependent Continuant
most specific type: Academic Article
language: Inglese

Generically Dependent Continuant
type: Class

2862339
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Anti-cancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.

Article
type: Class

Information Content Entity
type: Class

Inglese
type: Language